Ghada Miremont‐Salamé

Causality assessment in pharmacovigilance: The French method and its successive updates

Ghada Miremont‐Salamé, Hélène Théophile, Françoise Haramburu et al. · Therapies · 2016 · 230 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

Gianluca Trifirò, Preciosa M. Coloma, Jan A. Kors et al. · Pharmacoepidemiology and Drug Safety · 2009 · 181 citations

Pharmacy, Biomedical Informatics, Health Informatics +17

Differences between clinical trials and postmarketing use

Karin Martin, Bernard Bégaud, Philippe Latry et al. · British Journal of Clinical Pharmacology · 2003 · 152 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Incidence of hospital admissions due to adverse drug reactions in <scp>F</scp>rance: the <scp>EMIR</scp> study

Anne Bénard‐Laribière, Ghada Miremont‐Salamé, Marie‐Christine Pérault‐Pochat et al. · Fundamental and Clinical Pharmacology · 2014 · 132 citations

Pharmacy, Preventive Medicine, Drug Interactions +4

Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer

Marion Allouchery, Thomas Lombard, M. Martin et al. · Journal for ImmunoTherapy of Cancer · 2020 · 129 citations · Full text

Medicine, Oncology, Pharmacology +17